Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124204833 | 12420483 | 3 | F | 20160926 | 20160531 | 20160928 | EXP | PHHY2016CO074960 | NOVARTIS | 0.00 | F | Y | 42.00000 | KG | 20160928 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124204833 | 12420483 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 2 DF, Q12H | D | 22068 | 2 | DF | CAPSULE | Q12H | |||||
| 124204833 | 12420483 | 2 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124204833 | 12420483 | 1 | Chronic myeloid leukaemia |
| 124204833 | 12420483 | 2 | Blood pressure increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124204833 | 12420483 | Bone pain | |
| 124204833 | 12420483 | Discomfort | |
| 124204833 | 12420483 | Hyperhidrosis | |
| 124204833 | 12420483 | Pain | |
| 124204833 | 12420483 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124204833 | 12420483 | 1 | 20151111 | 0 |